Additional Effects on tDCS With AOT on Lower Limb Functions on Children With Diplegic CP (tDCS)

Inclusion Criteria:

1. Participants diagnosed with spastic diplegic cerebral palsy with a Modified Ashworth Scale (MAS) score of 2
2. Age between 6 to 12 years old
3. Participants classified as Communication Function Classification System (CFCS) Level II
4. Participant with CFCS Level II

Exclusion Criteria:

1. Presence of uncontrolled epilepsy (any seizure within the past 6 months).
2. Implanted metallic or electronic devices (e.g., pacemaker, cochlear implant, deep brain stimulator).
3. Severe dystonia, ataxia, or predominant weakness interfering with upper limb or lower limb function.
4. Severe visual impairment (not correctable with aids) preventing participation in action observation tasks.
5. Botulinum toxin injections in the affected limb(s) within the past 6 months or planned during study period.
6. Orthopedic surgery to the affected limb(s) within the past 12 months or planned during study period.
7. Skin conditions, lesions, or infections at electrode placement sites.
8. Current use of medications significantly affecting cortical excitability (e.g., high-dose benzodiazepines, anticonvulsants), unless cleared by neurologist.
9. Participation in another interventional clinical trial within the past 3 months.
10. Any medical or psychiatric condition that, in the investigator's judgment, makes participation unsafe or interferes with study outcomes.